GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amicus Therapeutics Inc (FRA:AM6) » Definitions » Inventories, Raw Materials & Components

Amicus Therapeutics (FRA:AM6) Inventories, Raw Materials & Components : €68.7 Mil (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Amicus Therapeutics Inventories, Raw Materials & Components?

Amicus Therapeutics's inventories, raw materials & components for the quarter that ended in Sep. 2024 was €68.7 Mil.

Amicus Therapeutics's quarterly raw materials increased from Mar. 2024 (€29.1 Mil) to Jun. 2024 (€41.7 Mil) and increased from Jun. 2024 (€41.7 Mil) to Sep. 2024 (€68.7 Mil).

Amicus Therapeutics's annual raw materials declined from Dec. 2021 (€10.9 Mil) to Dec. 2022 (€9.5 Mil) but then increased from Dec. 2022 (€9.5 Mil) to Dec. 2023 (€27.7 Mil).


Amicus Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Amicus Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicus Therapeutics Inventories, Raw Materials & Components Chart

Amicus Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.89 4.56 10.88 9.49 27.72

Amicus Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.79 27.72 29.08 41.72 68.66

Amicus Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Amicus Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
47 Hulfish Street, Princeton, NJ, USA, 08542
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Amicus Therapeutics Headlines

No Headlines